Iron sucrose
In clinical developmentAlso known as Ferric hydroxide sucrose complex, Iron oxide saccharated, Iron saccharate, Iron sucrose complex+7 more
Ferric hydroxide sucrose complex, Iron oxide saccharated, Iron saccharate, Iron sucrose complex, Iron sugar, Iron(III) hydroxide sucrose complex, Saccharated ferric oxide, Saccharated iron, Saccharated iron oxide, Sucrose Iron, Venofer.
Recent clinical, regulatory, research and industry developments relating to this drug.
Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- American journal of hematology1
- Kidney international1
- Achebe MM1
- Auerbach M1
- Derman RJ1
- Glaspy J1
- Henry D1
- Martinez CO1
- Mazey RM1
- McMurray S1
- Brigham and Women's Hospital1
- Department of Clinical and Non-clinical Research1
- Georgetown University School of Medicine1
- Pennsylvania Hospital1
- Thomas Jefferson University1
- UCLA School of Medicine1
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials